New program coming on-line at Bioquark Inc. (www.bioquark.com) — Ectocrine interactions (the“Ectocrinome”) represents a completely unexplored area related to human health
https://www.prweb.com/releases/bioquark_inc_and_ectocrine_te…004155.htm
Building on several years of research into a protein responsible for leukemia, a newly published paper has revealed success in slowing the progression of the deadly cancer in mouse models. The researchers suggest two new prospective therapies can now be combined into one “super drug” and progress into human clinical trials.
A potent molecular cocktail containing a compound from ayahuasca spurs rapid growth of insulin-producing cells.
Today, the application of engineering methodologies to the rational modification of organisms is a persistent goal of synthetic biology. Most synthetic biologists describe biological engineering as a hierarchy, wherein parts (genes, DNA) are used to build devices (many genes together), which in turn can be used to construct systems (a series of many devices). The challenge in transforming synthetic biology into a true engineering discipline is that the parts, which are the rudimentary building blocks of higher-order constructions, are fundamentally limited by the rigor of their characterization. This is really the case in all established engineering disciplines. In electrical engineering, for instance, the baseline components (transistors, resistors, wires, etc.) have been characterized so well that children can use them and the resulting circuits behave as expected. Once all ‘parts’ are standardized, it may be possible for synthetic biologists to use individual DNA building blocks to construct entirely synthetic life forms from the bottom-up.
Coming up with potent anti-cancer drugs is one thing, delivering them to the site of a tumor inside the body is very much another. With a complicated organism guarded by a highly evolved immune system to navigate, getting these particles to there target in one piece is a challenging task, and one that scientists are continuing to tackle from all angles. A promising new approach developed at Virginia Tech leans on the penetrative properties of a salmonella infection, which they’ve found can be used as a vehicle to smuggle cancer-fighting nanoparticles into a tumor in a huge abundance.
